[1]
A. Garcia Arieta, “A Survey of the Regulatory Requirements for the Waiver of In Vivo Bioequivalence Studies of Generic Products in Certain Dosage Forms by Participating Regulators and Organisations of the International Pharmaceutical Regulators Programme”, J Pharm Pharm Sci, vol. 24, pp. 113–126, Mar. 2021.